Stuttgart
14.07.26 | 11:04
9,960 Euro
+7,21 % +0,670
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 9,960 | 10,160 | 11:24 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:00 | Nexstim Oyj: Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor | 60 | GlobeNewswire (Europe) | Press Release, Helsinki, 14 July 2026 at 9 AM (EEST)
Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor
Nexstim Plc ("Nexstim" or "Company") has received a new order for ten NBS 6 systems... ► Artikel lesen | |
| 13.05. | Nexstim Oyj: Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option Holders | 297 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 13 May 2026 at 09:05 AM (EEST)
Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain... ► Artikel lesen | |
| 28.04. | Nexstim Oyj: Nexstim Plc Business Update Q1 2026 | 385 | GlobeNewswire (Europe) | Press release, Helsinki, 28 April 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q1 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 17.04. | Nexstim Oyj: Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029 | 160 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 17 April 2026 at 9 AM (EEST)
Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029
The Board of Directors of Nexstim... ► Artikel lesen | |
| 30.03. | Nexstim Oyj: Nexstim Plc: Resolutions of the Annual General Meeting | 171 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 March 2026 at 1:30 PM (EEST)
Nexstim Plc: Resolutions of the Annual General Meeting
Nexstim Plc ("Nexstim" or "Company") announces the following resolutions of the... ► Artikel lesen | |
| 23.03. | Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) | 344 | GlobeNewswire (Europe) | Press release, Helsinki, 23 March 2026 at 10:30 AM (EET)
Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
Nexstim Plc ("Nexstim" or "Company") announces... ► Artikel lesen | |
| 26.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2025 | 570 | GlobeNewswire (Europe) | Company announcement, Helsinki 26 February 2026 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2025
NEXSTIM ACCELERATED GROWTH AND ACHIEVED A PROFITABLE RESULT
January-December 2025
The... ► Artikel lesen | |
| 19.02. | Nexstim Oyj: Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation | 228 | GlobeNewswire (Europe) | Press release, Helsinki, 19 February 2026 at 9 AM (EET)
Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
Nexstim Plc ("Nexstim" or "Company") has... ► Artikel lesen | |
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| 16.02. | Nexstim Oyj: Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE | 494 | GlobeNewswire (Europe) | Press release, Helsinki, 16 February 2026 at 11:30 AM (EET)
Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE
Nexstim Plc ("Nexstim" or "Company") has received import clearance for... ► Artikel lesen | |
| 02.02. | Nexstim Oyj: Nexstim Receives System Order from Distributor in India | 320 | GlobeNewswire (Europe) | Press release, Helsinki, 2 February 2026 at 9 AM (EET)
Nexstim Receives System Order from Distributor in India
Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through... ► Artikel lesen | |
| 30.12.25 | Nexstim Oyj: US Customer Orders Two Nexstim NBS 6 Therapy Systems | 432 | GlobeNewswire (Europe) | Press release, Helsinki, 30 December 2025 at 9 AM (EET)
US Customer Orders Two Nexstim NBS 6 Therapy Systems
Nexstim Plc ("Nexstim" or "Company") has received an order for two NBS 6 therapy systems... ► Artikel lesen | |
| 23.12.25 | Nexstim Oyj: Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. | 250 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 23 December 2025 at 9 AM (EET)
Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc.
Nexstim Plc ("Nexstim"... ► Artikel lesen | |
| 16.09.25 | Nexstim Oyj: Nexstim Receives NBS 5+ System Order from Therapy Customer in United States | 236 | GlobeNewswire (Europe) | Press release, Helsinki, 16 September 2025 at 9 AM (EEST)
Nexstim Receives NBS 5+ System Order from Therapy Customer in United States
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| 15.08.25 | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2025 (unaudited) | 282 | GlobeNewswire (Europe) | NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2025 (UNAUDITED)
Company announcement, Helsinki, August 15, 2025 at 9 am (EEST)
NEXSTIM ACCELERATED GROWTH AND IMPROVED PROFITABILITY IN THE FIRST HALF... ► Artikel lesen | |
| 08.08.25 | Nexstim Oyj: Nexstim Receives NBS System 5 Order from India | 433 | GlobeNewswire (Europe) | Press release, Helsinki, 8 August 2025 at 10 AM (EEST)
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an Indian distributor.
The end customer is a hospital... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | HUB Cyber Security erwirbt Evofem-Anleihen im Tausch gegen eigene Aktien | ||
| VERU | 2,555 | -0,20 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| NYXOAH | 1,456 | -2,28 % | Nyxoah Announces Preliminary Results for the Second Quarter of 2026 | Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum drives second quarter global preliminary net revenue of €7.7 millionCMS proposes 2027 OPPS and ASC... ► Artikel lesen | |
| OPTOMED | 1,680 | -1,41 % | Optomed Oyj: Inside Information: Optomed receives a large order in the US | Optomed Plc Stock Exchange Release 18 June 2026 at 17.30, Helsinki
Inside Information: Optomed receives a large order in the US
Optomed has received an order of approximately USD 2.1 million (EUR... ► Artikel lesen | |
| MODULIGHT | 1,055 | -4,09 % | Modulight Oyj: Resolutions of Modulight Corporation's Annual General Meeting and Inaugural Meeting of the Board of Directors on 4 May 2026 | Modulight Corporation | Company Release | May 04, 2026 at 15:55:00 EEST
The Annual General Meeting of Modulight Corporation was held on 4 May 2026 at 1 p.m. (Finnish time) at Kampusareena Auditorium... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,63 | -0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| HEARTFLOW | 26,160 | 0,00 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| BILLIONTOONE | 123,25 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,380 | 0,00 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| PROGYNY | 31,990 | +0,03 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| ONCOLOGY INSTITUTE | 6,250 | 0,00 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| BETA BIONICS | 16,960 | +0,06 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 27,890 | 0,00 % | Privia Health Group, Inc. - 8-K, Current Report | ||
| GENEDX | 63,81 | -0,06 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| LIFESTANCE HEALTH GROUP | 10,875 | -0,05 % | LifeStance Health Group, Inc. - 8-K, Current Report |
NEXSTIM OYJ gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +7,21 % bei einem Aktienkurs von 9,960 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSTIM OYJ finden Sie auf Wallstreet Online.